Iodixanol pegol
Alternative Names: Iodixanol pegol nanoparticles - Marval Pharma; NCTX; PEGylated liposomal iodixanol injection - Marval PharmaLatest Information Update: 21 Apr 2016
At a glance
- Originator Marval Pharma
- Class Contrast media; Polyethylene glycols; Triiodobenzoic acids
- Mechanism of Action Emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atherosclerosis; Cancer; Cardiovascular disorders
Most Recent Events
- 09 Oct 2014 Marval Pharma terminates a phase I trial in Healthy volunteers in USA (NCT02063594)
- 06 Mar 2014 Phase-I clinical trials in Cancer and Cardiovascular disorders and Atherosclerosis (diagnosis; in volunteers) in USA (IV) (NCT02063594)